Data / Form D filings / MPX Bioceutical Corp
MPX Bioceutical Corp: Form D filing
MPX Bioceutical Corp, a pharmaceuticals company in Toronto, Ontario, Canada, filed a Form D with the SEC in 2018. The latest, on January 22, 2018, reports $2.5 million sold of a $2.5 million offering to 20 investors.
Find out what MPX Bioceutical Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5255 YONGE STREET, SUITE 701, Toronto, Ontario, Canada, M2N 6
- Phone
- (416) 840-3725
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1728215
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 22, 2018 | New notice | $2,480,000 | $2,480,000 | $0 | 20 | Jan 19, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David S. McLaren | Executive Officer | |
| Randall G. Stafford | Director | |
| Robert R. Galvin | Director | |
| Richard S. Segerblom | Director | |
| W. Scott Boyes | Executive Officer, Director | |
| Elizabeth M. Stavola | Executive Officer, Director | |
| Andrew R. Ryan | Director | |
| Miles D. Thompson | Director | |
| Jeremy S. Budd | Executive Officer |
Every Form D from the week of Jan 22, 2018 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what MPX Bioceutical Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.